Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies

By G. Shafiee, A. Keshtkar, A. Soltani, Z. Ahadi, B. Larijani, R. Heshmat. Journal of Diabetes and Metabolic Disorders, 2017

913 citations recorded by the source corpus.

BackgroundSarcopenia, an age-related decline in muscle mass and function, is one of the most important health problems in elderly with a high rate of adverse outcomes. However, several studies have investigated the prevalence of sarcopenia in the world, the results have been inconsistent. The current systematic review and meta- analysis study was conducted to estimate the overall prevalence of sarcopenia in both genders in different regions of the world.MethodsElectronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched between January 2009 and December 2016. The population- based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were selected. According to these consensual definitions, sarcopenia was defined by presence of low muscle mass (adjusted appendicular muscle mass for height) and muscle strength (handgrip strength) or physical performance (the usual gait speed).The random effect model was used for estimation the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia and 95% confidence interval (CI) were calculated using the Binomial Exact Method. Heterogeneity was assessed by subgroup analysis.ResultsThirty- five articles met our inclusion criteria, with a total of 58404 individuals. The overall estimates of prevalence was 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women, respectively. The prevalence was higher among non- Asian than Asian individuals in both genders especially, when the Bio-electrical Impedance Analysis (BIA) was used to measure muscle mass (19% vs 10% in men; 20% vs 11% in women).ConclusionDespite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass and different regions of the world for estimating parameters of sarcopenia, present systematic review revealed that a substantial proportion of the old people has sarcopenia, even in healthy populations. However, sarcopenia is as a consequence of the aging progress, early diagnosis can prevent some adverse outcomes.

Subfields: Geriatrics and Gerontology, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/5b96013919bca517ba3f3173442ab00cb29b47e1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

Citations in the corpus

Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. (2023, methodology): “In another meta-analysis of 58,404 community-dwelling participants aged 60 years and older, the overall global prevalence of sarcopenia was estimated to be 10 % and found to be slightly higher when using BIA compared to DXA to measure muscle quantity [15].”
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2021, background): “Moreover, even though previous systematic reviews and meta-analysis have reported the prevalence of sarcopenia in speci ﬁ c regions or communities, 14 – 16, 24, 25 this is the ﬁ rst study that reports the Across the available studies, there are wide variations in the estimated prevalence of…”